118 related articles for article (PubMed ID: 2118860)
21. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.
Tan SL; Maconochie N; Doyle P; Campbell S; Balen A; Bekir J; Brinsden P; Edwards RG; Jacobs HS
Am J Obstet Gynecol; 1994 Aug; 171(2):513-20. PubMed ID: 8059833
[TBL] [Abstract][Full Text] [Related]
22. Human menopausal gonadotrophin increases pregnancy rate in comparison with clomiphene citrate during replacement cycles of frozen/thawed pronucleate ova.
Van der Auwera I; Meuleman C; Koninckx PR
Hum Reprod; 1994 Aug; 9(8):1556-60. PubMed ID: 7989521
[TBL] [Abstract][Full Text] [Related]
23. [Factors affecting the results of in vitro fertilization--IV. Importance of the stimulation protocols combining GnRH analogs and HMG in women with unsuccessful stimulation with combinations of clomiphene citrate-HMG].
Mardesic T; Müller P; Zetová L; Miková M; Stroufová A
Ceska Gynekol; 1995 Apr; 60(2):74-8. PubMed ID: 7767590
[TBL] [Abstract][Full Text] [Related]
24. Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis.
Chedid S; Camus M; Smitz J; Van Steirteghem AC; Devroey P
Hum Reprod; 1995 Sep; 10(9):2406-11. PubMed ID: 8530675
[TBL] [Abstract][Full Text] [Related]
25. The use of the GnRH analogue buserelin for IVF--does it improve fertility?
Shelton K; Fishel S; Jackson P; Webster J; Faratian B; Johnson J
Br J Obstet Gynaecol; 1991 Jun; 98(6):544-9. PubMed ID: 1908314
[TBL] [Abstract][Full Text] [Related]
26. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
Hara S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
[TBL] [Abstract][Full Text] [Related]
27. Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG.
Smitz J; Devroey P; Braeckmans P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
Hum Reprod; 1987 May; 2(4):309-14. PubMed ID: 3114314
[TBL] [Abstract][Full Text] [Related]
28. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.
Balen AH; Tan SL; MacDougall J; Jacobs HS
Hum Reprod; 1993 Jun; 8(6):959-64. PubMed ID: 8345091
[TBL] [Abstract][Full Text] [Related]
29. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.
Rutherford AJ; Subak-Sharpe RJ; Dawson KJ; Margara RA; Franks S; Winston RM
Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1765-8. PubMed ID: 3136830
[TBL] [Abstract][Full Text] [Related]
30. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.
Lin YH; Hwang JL; Seow KM; Huang LW; Hsieh BC; Tzeng CR
Gynecol Endocrinol; 2006 Jun; 22(6):297-302. PubMed ID: 16785154
[TBL] [Abstract][Full Text] [Related]
31. In vitro fertilization with low-dose clomiphene citrate stimulation in women who respond poorly to superovulation.
Awonuga AO; Nabi A
J Assist Reprod Genet; 1997 Oct; 14(9):503-7. PubMed ID: 9401867
[TBL] [Abstract][Full Text] [Related]
32. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
Chen Y; Zhang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
[TBL] [Abstract][Full Text] [Related]
33. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization.
Tummon IS; Daniel SA; Kaplan BR; Nisker JA; Yuzpe AA
Fertil Steril; 1992 Sep; 58(3):563-8. PubMed ID: 1521653
[TBL] [Abstract][Full Text] [Related]
34. Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts.
Grimbizis G; Tarlatzis BC; Bontis J; Miliaras D; Lagos S; Pournaropoulos F; Mantalenakis S
Hum Reprod; 1995 Mar; 10(3):520-3. PubMed ID: 7782425
[TBL] [Abstract][Full Text] [Related]
35. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome.
Tanbo T; Dale PO; Kjekshus E; Haug E; Abyholm T
Fertil Steril; 1990 May; 53(5):798-803. PubMed ID: 2110071
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
[TBL] [Abstract][Full Text] [Related]
37. Ovarian stimulation of IVF patients: effects of the reversible hypogonadotrophic state induced by GnRH agonist.
Crosignani PG; Ragni G; Lombroso GC; Scarduelli C; De Lauretis L; Caccamo A; Dalprà L; Cavioni V; Cristiani C; Wyssling H
Hum Reprod; 1988 Oct; 3 Suppl 2():39-41. PubMed ID: 3147991
[TBL] [Abstract][Full Text] [Related]
38. Combined GnRH-agonist and HMG therapy in patients with stimulation failure.
Loutradis D; Kallianidis K; Siskos K; Bletsa R; Creatsas G; Michalas S; Aravantinos D
Int J Gynaecol Obstet; 1991 Dec; 36(4):317-21. PubMed ID: 1684765
[TBL] [Abstract][Full Text] [Related]
39. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
[TBL] [Abstract][Full Text] [Related]
40. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT.
Smitz J; Devroey P; Camus M; Deschacht J; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
Hum Reprod; 1988 Jul; 3(5):585-90. PubMed ID: 3139698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
